Abstract
SPECIALTY GRAND CHALLENGE article Front. Oncol., 02 October 2012 | https://doi.org/10.3389/fonc.2012.00127
Highlights
The advances in the field of medical oncology have led to an improved control of the systemic disease
Adjuvant chemotherapy and endocrine therapy became an important component of the treatment, aiming at the improvement of overall survival in breast, colon, and lung cancer
Her 2 inhibitors for breast cancer, imatinib for GIST, BRAF inhibitors for melanoma, EGFR tyrosine kinase inhibitors for non-small cell lung cancer are just some of the examples of targeted therapies that recently became standard treatments
Summary
The advances in the field of medical oncology have led to an improved control of the systemic disease. Adjuvant chemotherapy and endocrine therapy became an important component of the treatment, aiming at the improvement of overall survival in breast, colon, and lung cancer. More recently the new biomolecular targeted treatments pointed at increasing the therapeutic efficiency, sparing the oncological patient the debilitating side effects of the traditional chemotherapy.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
